MEDI-3617 is a humanized antibody targeting Ang2/ANGPT2/Angiopoietin2, inhibits loss of endothelial/smooth muscle cell contact, and can be used to study cardiovascular disease.
Anti-CD34 Antibody is a CHO-expressed humanized monoclonal antibody targeting CD34, which can be used for the study of neurological and cardiovascular diseases.
Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody with potential anticancer activity that can be used to study prostate cancer.